Table 1

Demographical and biological characteristics of patients with SARS-CoV-2 and SARS-CoV-2+

Patients with COVID-19
Median (IQR: Q1–Q3)
Patients with COVID-19+
Median (IQR: Q1–Q3)
P value
Age (years)80 (59.6–87.6)76.8 (56–86.3)0.64
Gender (%male)50501
BMI (kg/m²)28.5 (24.9–34.1)24.5 (22.4–26.2)0.067
Oxygen (RA/OT/MV)10/3/37/5/40.55
Hemoglobin (g/L)116 (100.5–123.5)116.5 (102–129.3)0.816
RBCs (T/L)3.9 (3.2–4.2)3.9 (3.3–4.5)0.59
MCV (fL)92.3 (89.7–96.6)90.2 (88.4–93.5)0.112
PC (109 /L)245.5 (120–321.8)205 (165.3–286.8)0.926
WBC (109 /L)9.7 (6.5–11.6)6.3 (4.4–8.8)0.088
Lymphocyte (109 /L)1.1 (0.7–1.8)1 (0.8–1.5)0.759
Iron (µmol/L)9.5 (7.5–11)6.5 (5–13.5)0.191
Transferrin (g/L)1.9 (1.1–2.3)1.6 (1.2–2)0.446
Transferrin saturation (%)23.6 (16–31.5)21.4 (14.2–27.1)0.545
Ferritin (µg/L)450 (237–761)600 (338–1495)0.346
sTfR (mg/L)3.5 (2.9–4.7)3.2 (2.6–4.8)0.574
CRP (mg/L)24.3 (5.1–75.2)38.8 (4.7–149)0.417
Hepcidin (nmol/L)14.2 (5.95–18.98)44.1 (16.55–70.48)0.003
ERFE (ng/mL)0.89 (0.19–3.82)0.16 (0.01–0.73)0.035
GDF-15 (pg/mL)4713 (2082–7774)2003 (1355–2447)0.015
  • BMI, body mass index; CRP, C reactive protein; ERFE, erythroferrone; GDF-15, growth differentiation factors 15; MCV, mean corpuscular volume; MV, mechanical ventilation; OT, oxygen therapy; PC, platelet count; RA, room air; RBC, red blood count; sTfR, soluble transferrin receptor; WBC, white blood cell.